methyl 2-(4-bromophenoxy)-2-methylpropanoate | 229980-47-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: methyl 2-(4-bromophenoxy)-2-methylpropanoate
• 英文别名: 2-(4-bromophenoxy)-2-methylpropanoic acid methyl ester；methyl 2-(4-bromophenoxy)-2-methylpropionate
• CAS: 229980-47-6
• 化学式: C₁₁H₁₃BrO₃
• mdl: MFCD19364127
• 分子量: 273.126
• InChiKey: MJBIEVZJGGUYSN-UHFFFAOYSA-N

物化性质

• 沸点：
  306.9±17.0 °C(Predicted)
• 密度：
  1.371±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  15
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  methyl 2-(4-bromophenoxy)-2-methylpropanoate 在 Wilkinson's catalyst 、 硼烷四氢呋喃络合物 、 hydrazine hydrate 、 氢气 、 palladium diacetate 、 1-羟基苯并三唑 、 三乙胺 、 N,N-二异丙基乙胺 、 三(邻甲基苯基)磷 、 sodium hydroxide 、 N,N'-二异丙基碳二亚胺 作用下， 以 四氢呋喃 、 乙醇 、 二氯甲烷 、 乙腈 为溶剂， 20.0 ℃ 、405.33 kPa 条件下， 反应 67.5h， 生成 2-(4-{2-[N-(heptyl)-N-(benzoxazol-2-yl)amino]ethyl}phenoxy)-2-methylpropanoic acid
  参考文献：
  名称：

  Synthesis, Characterization and Biological Evaluation of Ureidofibrate-Like Derivatives Endowed with Peroxisome Proliferator-Activated Receptor Activity

  摘要：

  A series of ureidofibrate-like derivatives was prepared and assayed for their PPAR functional activity. A calorimetric approach was used to characterize PPAR gamma-ligand interactions, and docking experiments and X-ray studies were performed to explain the observed potency and efficacy. R-1 and S-1 were selected to evaluate several aspects of their biological activity. In an adipogenic assay, both enantiomers increased the expression of PPAR gamma target genes and promoted the differentiation of 3T3-L1 fibroblasts to adipocytes. In vivo administration of these compounds to insulin resistant C57Bl/6J mice fed a high fat diet reduced visceral fat content and body weight. Examination of different metabolic parameters showed that R-1 and S-1 are insulin sensitizers. Notably, they also enhanced the expression of hepatic PPAR alpha target genes indicating that their in vivo effects stemmed from an activation of both PPAR alpha and gamma. Finally, the capability of R-1 and S-1 to inhibit cellular proliferation in colon cancer cell lines was also evaluated.

  DOI：

  10.1021/jm201306q
• 作为产物：
  描述：

  2-(4-溴苯氧基)-2-甲基丙酸 在 氯化亚砜 、 三乙胺 作用下， 以 四氢呋喃 、 DMF (N,N-dimethyl-formamide) 为溶剂， 反应 6.0h， 生成 methyl 2-(4-bromophenoxy)-2-methylpropanoate
  参考文献：
  名称：

  [EN] INDOLES USEFUL IN THE TREATMENT OF INFLAMMATION
  [FR] INDOLES UTILISES DANS LE TRAITEMENT D'INFLAMMATIONS

  摘要：

  提供一种化合物，其化学式为：(I)，其中X、R1、R2、R3、R4、R5和R6的含义如描述中所示，以及其药用盐，这些化合物在需要或希望抑制微粒体前列腺素E合成酶-1活性的疾病治疗中非常有用，特别是在炎症治疗中。

  公开号：

  WO2005123673A1

文献信息

• Morpholine Compound
  申请人：Tanaka Yoshihito

  公开号：US20070265257A1

  公开（公告）日：2007-11-15

  A compound represented by the formula (1) wherein ring A is aryl optionally having substituent(s) and the like; ring B is arylene optionally having substituent(s) and the like; m=0-2; n=1-5; X is a bond and the like; Y is a bond and the like; and Z is hydrogen atom and the like or a pharmaceutically acceptable salt thereof, and a hydrate or solvate thereof have affinity for CCR3, and can be pharmaceutical products for the treatment and/or prophylaxis of immune or inflammatory diseases.

  化合物的化学式为(1)，其中环A是芳基，可选地具有取代基等；环B是芳烃，可选地具有取代基等；m=0-2；n=1-5；X是键等；Y是键等；Z是氢原子等或其药学上可接受的盐，其水合物或溶剂化物具有对CCR3的亲和力，并可用于治疗和/或预防免疫或炎症性疾病的药物产品。
• Indoles Useful in the Treatment of Inflammation
  申请人：Olofsson Kristofer

  公开号：US20070287715A1

  公开（公告）日：2007-12-13

  There is provided a compound of formula: (I), wherein X, R 1 , R 2 , R 3 , R 4 , R 5 and R 6 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of microsomal prostaglandin E synthase-1 is desired and/or required, and particularly in the treatment of inflammation.

  提供了一个公式为（I）的化合物，其中X，R1，R2，R3，R4，R5和R6在描述中有给定的含义，以及其药学上可接受的盐。这些化合物在治疗需要抑制微粒体前列腺素E合成酶-1活性的疾病，特别是在治疗炎症方面是有用的。
• Morpholine compound
  申请人：Mitsubishi Tanabe Pharma Corporation

  公开号：US07935700B2

  公开（公告）日：2011-05-03

  A compound represented by the formula (1) wherein ring A is aryl optionally having substituent(s) and the like; ring B is arylene optionally having substituent(s) and the like; m=0-2; n=1-5; X is a bond and the like; Y is a bond and the like; and Z is hydrogen atom and the like or a pharmaceutically acceptable salt thereof, and a hydrate or solvate thereof have affinity for CCR3, and can be pharmaceutical products for the treatment and/or prophylaxis of immune or inflammatory diseases.

  化合物的化学式为（1），其中环A是芳基，可以选择地具有取代基等；环B是芳烃，可以选择地具有取代基等；m = 0-2；n = 1-5；X是键等；Y是键等；Z是氢原子等或其药学上可接受的盐，其水合物或溶剂化物具有对CCR3的亲和力，并可用作治疗和/或预防免疫或炎症性疾病的药物产品。
• Indoles useful in the treatment of inflammation
  申请人：Biolipox AB

  公开号：US07705023B2

  公开（公告）日：2010-04-27

  There is provided a compound of formula: (I), wherein X, R1, R2, R3, R4, R5 and R6 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of microsomal prostaglandin E synthase-1 is desired and/or required, and particularly in the treatment of inflammation.

  提供了一种化合物，其化学式为（I），其中X、R1、R2、R3、R4、R5和R6的含义如描述所示，并且其药学上可接受的盐，这些化合物在治疗需要和/或期望抑制微粒体前列腺素E合成酶-1活性的疾病中很有用，特别是在治疗炎症方面。
• MORPHOLINE COMPOUND
  申请人：Mitsubishi Pharma Corporation

  公开号：EP1801108A1

  公开（公告）日：2007-06-27

  A compound represented by the formula (1) wherein ring A is aryl optionally having substituent(s) and the like; ring B is arylene optionally having substituent(s) and the like; m=0-2; n=1-5; X is a bond and the like; Y is a bond and the like; and Z is hydrogen atom and the like or a pharmaceutically acceptable salt thereof, and a hydrate or solvate thereof have affinity for CCR3, and can be pharmaceutical products for the treatment and/or prophylaxis of immune or inflammatory diseases.

  由式（1）代表的化合物 其中，环 A 是可选具有取代基等的芳基；环 B 是可选具有取代基等的芳烯；m=0-2；n=1-5；X 是键等；Y 是键等；Z 是氢原子等，或其药学上可接受的盐、水合物或溶液对 CCR3 具有亲和力，可作为治疗和/或预防免疫性或炎症性疾病的药物产品。